Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Stage II, Stage I”

231 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 231 results

Testing effectiveness (Phase 2)Study completedNCT00068172
What this trial is testing

Study of PI-88 in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Cellxpert Biotechnology Corp. 88
Testing effectiveness (Phase 2)UnknownNCT01614301
What this trial is testing

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
University of Regensburg 136
Testing effectiveness (Phase 2)UnknownNCT00538005
What this trial is testing

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 54
Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63
Testing effectiveness (Phase 2)UnknownNCT01331915
What this trial is testing

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients

Who this might be right for
Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 23
Testing effectiveness (Phase 2)Ended earlyNCT00724841
What this trial is testing

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Gemin X 1
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT03374839
What this trial is testing

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Nantes University Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT02706353
What this trial is testing

APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT00049010
What this trial is testing

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 314
Large-scale testing (Phase 3)Study completedNCT00004196
What this trial is testing

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 3,000
Testing effectiveness (Phase 2)Study completedNCT00073892
What this trial is testing

PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Cellxpert Biotechnology Corp. 44
Testing effectiveness (Phase 2)Study completedNCT00020358
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00429312
What this trial is testing

Recombinant Vaccinia Virus to Treat Malignant Melanoma

Who this might be right for
Melanoma
Jennerex Biotherapeutics 10
Early research (Phase 1)Ended earlyNCT00791271
What this trial is testing

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 17
Not applicableLooking for participantsNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 250
Testing effectiveness (Phase 2)Study completedNCT02308553
What this trial is testing

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 33
Testing effectiveness (Phase 2)Study completedNCT03555032
What this trial is testing

TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)

Who this might be right for
Melanoma and Sarcoma
Royal Marsden NHS Foundation Trust 15
Load More Results